CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a more efficient synthesis method for prostaglandins, which are important chemical messengers used in various medical applications, including glaucoma treatment. The goal is to reduce the production cost significantly, making it more feasible for pharmaceutical industries to manufactu…
Prostaglandins (PGs) are hormone-like chemical messengers that regulate a broad range of physiological activities, essential to life.
Some synthetic analogues of prostaglandin are ‘billion dollar’ drugs e.g. latanoprost, which is used to treat glaucoma.
The whole family of PG drugs (around 30 members) have combined annual sales of >$10bn pa.
Furthermore a new dermatological application of PGs against reduction in adipose tissue (i.e. fat) discovered by Topokine is set to dwarf these numbers and,…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
